Washington 2023-2024 Regular Session Status: Passed House Bipartisan · 4 D · 1 R cosponsors

HB 1450 — Concerning coverage for biomarker testing.

Last action — Referred to Appropriations.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2023-2024 Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

152 added · 154 removed

Plain-language change summary

The latest version of HB 1450 broadens the scope of diagnostic tests covered by health insurers by removing the specific limitation to stage 1 to 4 cancers and brain cancer. This change means that more patients with various diseases may have access to necessary testing without facing delays or additional procedures. By ensuring wider coverage, the bill aims to provide patients with timely and effective care based on their individual health needs. This can lead to earlier interventions and potentially better outcomes for all patients who require testing for their conditions.

→
Previous
Latest
H-1173.1 SUBSTITUTE HOUSE BILL 1450 State of Washington 68th Legislature 2023 Regular Session By House Health Care & Wellness (originally sponsored by Representatives Stonier, Harris, Simmons, Reed, and Macri) READ FIRST TIME 02/10/23.
H-0621.1 HOUSE BILL 1450 State of Washington 68th Legislature 2023 Regular Session By Representatives Stonier, Harris, Simmons, Reed, and Macri Read first time 01/19/23.
Referred to Committee on Health Care & Wellness.
(1) For health plans issued or renewed on or after January 1, 2024, a health carrier shall include coverage for biomarker testing for stage 1, 2, 3, or 4 cancer and brain cancer pursuant to the criteria established under subsection (2) of this section.
(1) For health plans issued or renewed on or after January 1, 2024, a health carrier shall include coverage for biomarker testing pursuant to the criteria established under subsection (2) of this section.
(2) Biomarker testing must be covered for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's stage 1, 2, 3, or 4 cancer or brain cancer when the test is supported by medical and scientific evidence including, but not limited to:
(2) Biomarker testing must be covered for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's disease or condition when the test is supported by medical and scientific evidence including, but not limited to:
p.
(c) Nationally recognized clinical practice guidelines;
1 SHB 1450 (c) Nationally recognized clinical practice guidelines;
or p.
or (d) Consensus statements.
1 HB 1450 (d) Consensus statements.
(1) A health plan offered to public employees and their covered dependents under this chapter issued or renewed on or after January 1, 2024, shall include coverage for biomarker testing for stage 1, 2, 3, or 4 cancer and brain cancer pursuant to the criteria established under subsection (2) of this section.
(1) A health plan offered to public employees and their covered dependents under this chapter issued or renewed on or after January 1, 2024, shall include coverage for biomarker testing pursuant to the criteria established under subsection (2) of this section.
p.
(2) Biomarker testing must be covered for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring p.
2 SHB 1450 (2) Biomarker testing must be covered for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's stage 1, 2, 3, or 4 cancer or brain cancer when the test is supported by medical and scientific evidence including, but not limited to:
2 HB 1450 of an enrollee's disease or condition when the test is supported by medical and scientific evidence including, but not limited to:
p.
(ii) Establish standards of care informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options;
3 SHB 1450 (ii) Establish standards of care informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options;
NEW SECTION.
p.
3 HB 1450 NEW SECTION.
(1) Beginning January 1, 2024, the authority shall provide coverage under this chapter for biomarker testing for stage 1, 2, 3, or 4 cancer and brain cancer pursuant to the criteria established under subsection (2) of this section.
(1) Beginning January 1, 2024, the authority shall provide coverage under this chapter for biomarker testing pursuant to the criteria established under subsection (2) of this section.
(2) Biomarker testing must be covered for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's stage 1, 2, 3, or 4 cancer or brain cancer when the test is supported by medical and scientific evidence including, but not limited to:
(2) Biomarker testing must be covered for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's disease or condition when the test is supported by medical and scientific evidence including, but not limited to:
p.
(b) "Biomarker testing" means the analysis of a patient's tissue, blood, or other biospecimen for the presence of a biomarker.
4 SHB 1450 (b) "Biomarker testing" means the analysis of a patient's tissue, blood, or other biospecimen for the presence of a biomarker.
(ii) Aimed at specific clinical circumstances;
p.
4 HB 1450 (ii) Aimed at specific clinical circumstances;
5 SHB 1450
5 HB 1450
⬇ Download PDF
View plain text versions (3)

Action History

  1. Referred to Appropriations.

  2. HCW - Majority; 2nd substitute bill be substituted, do pass.

  3. Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.

  4. Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.

  5. Referred to Health Care & Wellness.

  6. Committee relieved of further consideration.

  7. By resolution, reintroduced and retained in present status.

  8. Referred to Appropriations.

  9. Minority; do not pass.

  10. HCW - Majority; 1st substitute bill be substituted, do pass.

  11. Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.

  12. Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.

  13. First reading, referred to Health Care & Wellness.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 4 co-sponsors · 146 not signed on

Sponsors (1)

Co-sponsors (4)

Not signed on (146)

146 members have not signed on to this bill.

Show all 146 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 1450?
HB 1450 is sponsored by Nicole Macri (Democrat), Julia Reed (Democrat), Tarra Simmons (Democrat), Paul Harris (Republican), and Monica Jurado Stonier (Democrat).
What is the current status of HB 1450?
This bill died with 2023-2024 Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 1450?
Track HB 1450 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 1450

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 1450

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →